Don’t invest unless you're prepared to lose money. This is a high-risk investment. You may not be able to access your money easily and are unlikely to be protected if something goes wrong. Take 2 mins to learn more.

Our small businesses helping to fight COVID-19

Since the outbreak of the COVID-19 virus, a great deal of our Crowd2Fund businesses have responded to government led-efforts to in defeating the virus. We have showcased only five of many, and we thank our entrepreneurs, and hope that they inspire many more initiatives.

15th April 2020

Since the outbreak of the COVID-19 virus, a great deal of our Crowd2Fund businesses have responded to government led-efforts to in defeating the virus. We have showcased only five of many, and we thank our entrepreneurs for their efforts and hope that they inspire many more initiatives.

Titanium Dioxide lights that kill COVID-19 - Adrian Ladds, founder of Power On Demand  

Our long-standing client, Power on Demand raised money with us to expand their solar energy company. They recently approached us with their new licensed TiO2 LED product that kills the airborne and surface-based COVID-19. 

They are now looking to perform UK based tests for installation of these LEDs, which are coated with a special chemical called Titanium Dioxide or TiO2. These lights will be installed indoors in areas at high risk of contamination. 

The TiO2 panels are an extremely effective biocide for both bacteria and viruses and have been readily adopted by governments. There are many research papers from the University of Tokyo — who discovered the properties of TiO2 — to show how it actually works. Viricidal testing was done in the US by a laboratory approved by the FDA and showed a 99.99% elimination rate. 

Emergency protective equipment - Hugh Clow, director of Planks 

With the goal to grow their ski clothing equipment company, Planks have done multiple rounds of funding via the Crowd2Fund platform. They have now pivoted their South East Asian supply chain to sourcing personal protective equipment (PPE) to meet any additional demand the UK government has. 

At home with designing protective equipment for free-ride skiers, they are currently focused on sourcing the PPE products from factories around Asia – creating a vital lifeline for government procurement processes if needed. They are also considering adapting their ski gear clothing into a highly durable and reusable heavy-duty personal protective equipment, supporting our front-line health workers who are at the highest risk of exposure. 

Manufactured parts for ventilators - Richard Preston, director of NDT Equipment Supplies 

Established in 1990, NDT Equipment Supplies has become the largest supplier of ultrasound equipment in Europe. The UK business has now turned its hand from delivering the highly technical ultrasound equipment to delivering similar parts for ventilators, in collaboration with larger engineering companies such as AMG and McLaren. 

They are looking to manufacture precision parts for the ventilators using their machine-tooling and milling machines. They are also looking further afield to support African manufacturers if required further down the line, due to the massive shortage of ventilators in developing countries. 

Prefabricated medical isolation units - Ian Strangward, founder of Architectural Wallsz 

Used to developing internal meeting rooms for offices, Ian and his firm Architectural Wallsz have switched their skills to isolation units. Based in Alvechurch, Worcestershire, his team invented DIRRT — an isolation unit with an incredible production time of 10 days for 500 isolation units. 

It’s a building process powered by technology and advanced manufacturing. Walls, doors, power, and medical gas are all rapidly designed and built with extreme precision in the DIRTT factories. They are now turning their attention to the demand in the US. 

Finally, a potential treatment for COVID-19 from one of our Investors 

One of our investors is involved with a pharmaceutical product, contacted us about a UK-owned and manufactured drug that has shown promising results according to recently conducted tests in Italy. This fledgeling COVID-19 treatment is called SYLVANT®. SYLVANT has the capability to stop the body’s autoimmune response reaction, potentially reducing the number of patients that need mechanical ventilation. While still early, we hope to hear continued positive progress. 

As we all know, everything is happening incredibly quickly and changing every day. We are incredibly proud of what our community are doing during this crisis to provide solutions for the challenges thrown by the dreadful COVID-19 virus. 

At Crowd2Fund, we will support you and your business’s efforts to help; assist in channelling them to the correct government departments, and provide financial support if needed to ensure these solutions get reviewed and procured by the right teams – your efforts are needed and invaluable. 

Contact us to let us know what can you do to help the fight on


Related Posts

Our Loan Book Update

Our Loan Book Update

Posted: 16th November 2021

Two perspectives: The Crowd2Fund portfolio of 565 listings over 7 years

Internal Operations Overload

Internal Operations Overload

Posted: 2nd September 2019

Sustainable expansion requires the establishment of consistent processes, roles, and responsibilitie...

Growing Your Business With Intent

Growing Your Business With Intent

Posted: 31st July 2019

How to transition from a start-up to a high-growth company.

Risk warning

Past performance and forecasts are not reliable indicators of future results. Your capital invested is not covered for compensation in the event of a loss by the FSCS. Tax treatment will depend on the individual circumstances and may be subject to change. Please see our Risk section before making an investment decision.